Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proposal for a tailored stratification at baseline and monitoring of cardiovascular effects during follow-up in chronic phase chronic myeloid leukemia patients treated with nilotinib frontline.
Breccia M, Arboscello E, Bellodi A, Colafigli G, Molica M, Bergamaschi M, Massaro F, Quattrocchi L, Sarocchi M, Spallarossa P, Alimena G. Breccia M, et al. Among authors: quattrocchi l. Crit Rev Oncol Hematol. 2016 Nov;107:190-198. doi: 10.1016/j.critrevonc.2016.10.002. Epub 2016 Oct 15. Crit Rev Oncol Hematol. 2016. PMID: 27823647 Review.
Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?
Latagliata R, Breccia M, Carmosino I, Cesini L, De Benedittis D, Mohamed S, Vozella F, Molica M, Campanelli M, De Luca ML, Colafigli G, Quattrocchi L, Loglisci MG, Massaro F, Canichella M, Diverio D, Mancini M, Alimena G, Foà R. Latagliata R, et al. Among authors: quattrocchi l. Eur J Haematol. 2018 Jun 13. doi: 10.1111/ejh.13110. Online ahead of print. Eur J Haematol. 2018. PMID: 29896890
Mediastinal isolated myeloid sarcoma: a single-institution experience.
D'angiò M, Paesano P, Quattrocchi L, Barberi W, Ceglie T, Avagnina I, de Propris MS, Trisolini S, Testi AM. D'angiò M, et al. Among authors: quattrocchi l. Leuk Lymphoma. 2015 Feb;56(2):539-41. doi: 10.3109/10428194.2014.914201. Epub 2015 Feb 4. Leuk Lymphoma. 2015. PMID: 24730541 No abstract available.
Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience.
Bruzzese A, Assanto GM, Diverio D, Quattrocchi L, Carmini D, La Rocca U, De Propris MS, Trisolini SM, Brescini M, Galassi G, Barberi W, Iori AP. Bruzzese A, et al. Among authors: quattrocchi l. Bone Marrow Transplant. 2021 Jun;56(6):1455-1457. doi: 10.1038/s41409-020-01174-w. Epub 2021 Jan 29. Bone Marrow Transplant. 2021. PMID: 33514926 No abstract available.
24 results